These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 14633084

  • 1. Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis.
    Vieira MM, Brito GA, Belarmino-Filho JN, Macedo FY, Nery EA, Cunha FQ, Ribeiro RA.
    Int J Urol; 2003 Nov; 10(11):595-602. PubMed ID: 14633084
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats.
    Macedo FY, Baltazar F, Almeida PR, Távora F, Ferreira FV, Schmitt FC, Brito GA, Ribeiro RA.
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):19-27. PubMed ID: 17638016
    [Abstract] [Full Text] [Related]

  • 3. Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats.
    Vieira MM, Macêdo FY, Filho JN, Costa AC, Cunha AN, Silveira ER, Brito GA, Ribeiro RA.
    Phytother Res; 2004 Feb; 18(2):135-41. PubMed ID: 15022166
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.
    Morais MM, Belarmino-Filho JN, Brito GA, Ribeiro RA.
    Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
    Ozguven AA, Yılmaz O, Taneli F, Ulman C, Vatansever S, Onag A.
    Indian J Pharmacol; 2014 Oct; 46(2):147-51. PubMed ID: 24741183
    [Abstract] [Full Text] [Related]

  • 6. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
    Batista CK, Mota JM, Souza ML, Leitão BT, Souza MH, Brito GA, Cunha FQ, Ribeiro RA.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
    [Abstract] [Full Text] [Related]

  • 7. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA, Danda SK, Basha SA, Rasheed A, Ahmed O, Ahmed MM.
    Indian J Pharmacol; 2014 Jan; 46(1):105-8. PubMed ID: 24550594
    [Abstract] [Full Text] [Related]

  • 8. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF, Pereira VBM, Wong DVT, Nobre LMS, Melo AT, Silva CMS, Wanderley CWS, Nour ML, Araújo LCNC, Silva RO, Pinto FMM, Bingana RD, Souza MHLP, Alencar NMN, Silva PGB, Alves APNN, Almeida PRC, Cunha FQ, Lima-Júnior RCP.
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [Abstract] [Full Text] [Related]

  • 9. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
    Lima MV, Ferreira FV, Macedo FY, de Castro Brito GA, Ribeiro RA.
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):643-50. PubMed ID: 16947012
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Mota JM, Brito GA, Loiola RT, Cunha FQ, Ribeiro Rde A.
    Int Braz J Urol; 2007 Apr; 33(5):704-10. PubMed ID: 17980069
    [Abstract] [Full Text] [Related]

  • 11. Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.
    Santos AA, Leal PC, Edelweiss MI, Lopes TG, Calixto JB, Morrone FB, Campos MM.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):399-407. PubMed ID: 20809237
    [Abstract] [Full Text] [Related]

  • 12. Combined intravenous and oral mesna in outpatients treated with ifosfamide.
    Goren MP, McKenna LM, Goodman TL.
    Cancer Chemother Pharmacol; 1997 Dec; 40(5):371-5. PubMed ID: 9272112
    [Abstract] [Full Text] [Related]

  • 13. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.
    Matz EL, Hsieh MH.
    Urology; 2017 Feb; 100():16-19. PubMed ID: 27566144
    [Abstract] [Full Text] [Related]

  • 14. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
    [Abstract] [Full Text] [Related]

  • 15. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A, Korkmaz A, Oter S, Coskun O.
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [Abstract] [Full Text] [Related]

  • 16. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [Abstract] [Full Text] [Related]

  • 17. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sano T, Suemasu K, Jett JR.
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [Abstract] [Full Text] [Related]

  • 18. Target Inhibition of IL-1 Receptor Prevents Ifosfamide Induced Hemorrhagic Cystitis in Mice.
    Leite CA, Alencar VT, Melo DL, Mota JM, Melo PH, Mourão LT, Wong DV, Magalhães PJ, Santos AA, Brito GA, Lima-Júnior RC, Cunha FQ, Ribeiro RA.
    J Urol; 2015 Dec; 194(6):1777-86. PubMed ID: 26220217
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice.
    Song J, Liu L, Li L, Liu J, Song E, Song Y.
    Cell Biochem Funct; 2014 Mar; 32(2):125-32. PubMed ID: 23650119
    [Abstract] [Full Text] [Related]

  • 20. [Ifosfamide-induced urinary bladder lesion and its inhibition by mesna].
    Muraoka Y, Watanabe H, Matsui S, Nara H, Kasai H.
    Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):73-83. PubMed ID: 2121633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.